{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:54:31Z","timestamp":1790096071461,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1006\/gyno.1999.5664","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T18:50:18Z","timestamp":1032288618000},"page":"294-300","source":"Crossref","is-referenced-by-count":53,"title":["Reduction of BRCA1 Expression in Sporadic Ovarian Cancer"],"prefix":"10.1006","volume":"76","author":[{"given":"Wenxin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean J.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armine","family":"Baltayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1999.5664_RF1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1006\/gyno.1999.5664_RF2","first-page":"399","article-title":"Molecular genetics of hereditary ovarian cancer","volume":"12","author":"Boyd","year":"1998","journal-title":"Oncology (Huntingt)"},{"key":"10.1006\/gyno.1999.5664_RF3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng0495-444","article-title":"Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression","volume":"9","author":"Thompson","year":"1995","journal-title":"Nat Genet"},{"key":"10.1006\/gyno.1999.5664_RF4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ng0396-298","article-title":"Growth retardation and tumour inhibition by BRCA1","volume":"12","author":"Holt","year":"1996","journal-title":"Nat Genet"},{"key":"10.1006\/gyno.1999.5664_RF5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-4608(97)00267-7","article-title":"Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype","volume":"101","author":"Jarvis","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1006\/gyno.1999.5664_RF6","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.onc.1202248","article-title":"Down-regulation of BRCA1 in human sporadic breast cancer, analysis of DNA methylation patterns of the putative promoter region","volume":"17","author":"Magdinier","year":"1998","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5664_RF7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/bbrc.1998.8379","article-title":"Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors","volume":"245","author":"Sourvinos","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1006\/gyno.1999.5664_RF8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/6029","article-title":"Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas","volume":"21","author":"Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"10.1006\/gyno.1999.5664_RF9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng0995-17","article-title":"The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues","volume":"11","author":"Marquis","year":"1995","journal-title":"Nat Genet"},{"key":"10.1006\/gyno.1999.5664_RF10","first-page":"717","article-title":"Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells","volume":"7","author":"Gudas","year":"1996","journal-title":"Cell Growth Different"},{"key":"10.1006\/gyno.1999.5664_RF11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.1711680404","article-title":"Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections","volume":"168","author":"Cattoretti","year":"1992","journal-title":"J Pathol"},{"key":"10.1006\/gyno.1999.5664_RF12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/gyno.1998.4958","article-title":"Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer","volume":"69","author":"Zheng","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5664_RF13","first-page":"419","article-title":"BRCA1 is expressed independently of hormonal stimulation in the mouse ovary","volume":"76","author":"Phillips","year":"1997","journal-title":"Lab Invest"},{"key":"10.1006\/gyno.1999.5664_RF14","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jcp.46.12.1080","article-title":"New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections","volume":"46","author":"Key","year":"1993","journal-title":"J Clin Pathol"},{"key":"10.1006\/gyno.1999.5664_RF15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0301-2115(97)00169-3","article-title":"Ki 67 expression in 35 borderline ovarian tumours: relations with clinicopathologic parameters and ploidy","volume":"76","author":"Darai","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1006\/gyno.1999.5664_RF16","first-page":"444","article-title":"Quantitation of targets for PCR by use of limiting dilution","volume":"13","author":"Sykes","year":"1992","journal-title":"BioTechniques"},{"key":"10.1006\/gyno.1999.5664_RF17","unstructured":"SAS\/STAT User Guide, Version 6, Cary, NC, SAS Institute, Inc, 1990"},{"key":"10.1006\/gyno.1999.5664_RF18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng0495-343","article-title":"A somatic BRCA1 mutation in an ovarian tumour","volume":"9","author":"Hosking","year":"1995","journal-title":"Nat Genet"},{"key":"10.1006\/gyno.1999.5664_RF19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ng0495-439","article-title":"Somatic mutations in the BRCA1 gene in sporadic ovarian tumours","volume":"9","author":"Merajver","year":"1995","journal-title":"Nat Genet"},{"key":"10.1006\/gyno.1999.5664_RF20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-4608(99)00005-9","article-title":"Classification of IVS1-10T\u2192C as a polymorphism of BRCA1","volume":"113","author":"Fetzer","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1006\/gyno.1999.5664_RF21","first-page":"1581","article-title":"Allele loss from chromosome 17 in ovarian cancer","volume":"5","author":"Russell","year":"1990","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5664_RF22","first-page":"735","article-title":"A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer","volume":"12","author":"Tangir","year":"1996","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5664_RF23","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1006\/gyno.1999.5664_RF24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.genet.30.1.441","article-title":"The role of DNA methylation in cancer genetic and epigenetics","volume":"30","author":"Laird","year":"1996","journal-title":"Ann Rev Genet"},{"key":"10.1006\/gyno.1999.5664_RF25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-230X(08)60702-2","article-title":"Alterations in DNA methylation: a fundamental aspect of neoplasia","volume":"72","author":"Baylin","year":"1998","journal-title":"Adv Cancer Res"},{"key":"10.1006\/gyno.1999.5664_RF26","first-page":"3347","article-title":"Methylation of the BRCA1 gene in sporadic breast cancer","volume":"57","author":"Dobrovic","year":"1997","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1999.5664_RF27","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/sj.onc.1202086","article-title":"Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells","volume":"17","author":"Rice","year":"1998","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5664_RF28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(00)81847-4","article-title":"Association of BRCA1 with Rad51 in mitotic and meiotic cells","volume":"88","author":"Scully","year":"1997","journal-title":"Cell"},{"key":"10.1006\/gyno.1999.5664_RF29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(00)80503-6","article-title":"Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage","volume":"90","author":"Scully","year":"1997","journal-title":"Cell"},{"key":"10.1006\/gyno.1999.5664_RF30","first-page":"801","article-title":"Induction of phosphorylation of BRCA1 during the cell cycle and after DNA damage","volume":"8","author":"Thomas","year":"1997","journal-title":"Cell Growth Different"},{"key":"10.1006\/gyno.1999.5664_RF31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(00)80276-2","article-title":"Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells","volume":"2","author":"Chen","year":"1998","journal-title":"Mol Cell"},{"key":"10.1006\/gyno.1999.5664_RF32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9343(96)80079-9","article-title":"Borderline ovarian tumors","volume":"101","author":"Link","year":"1996","journal-title":"Am J Med"},{"key":"10.1006\/gyno.1999.5664_RF33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-642-74011-4_5","article-title":"Prognostic significance of pathologic features of ovarian carcinoma","volume":"78","author":"Silverberg","year":"1989","journal-title":"Curr Topic Pathol"},{"key":"10.1006\/gyno.1999.5664_RF34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/path.1711620404","article-title":"Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival","volume":"162","author":"Isola","year":"1990","journal-title":"J Pathol"},{"key":"10.1006\/gyno.1999.5664_RF35","first-page":"868","article-title":"Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer","volume":"59","author":"Pharoah","year":"1999","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1999.5664_RF36","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899956640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899956640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T04:56:42Z","timestamp":1557377802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825899956640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0090825899956640"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1999.5664","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}